Guanabenz

CAS : 5051-62-7

Ref. 3D-FAA05162

Informations sur le produit

• Nom: Guanabenz
• Synonymes: 2-[(2,6-Dichlorophenyl)methylene]hydrazinecarboximidamide, Amino{[(2,6-Dichlorophenyl)Methylidene]Hydrazono}Methanaminium, Guanabenzo, Guanidine, [(2,6-dichlorobenzylidene)amino]-, Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, N''-(2,6-dichlorobenzylidene)carbonohydrazonic diamide, N''-[(1E)-(2,6-dichlorophenyl)methylidene]carbonohydrazonic diamide, N-(2,6-Dichlorobenzylidene)-N'-amidinohydrazine, Nsc 68982, Wy 8678, [(2,6-Dichlorobenzylidene)amino]guanidine

Description

Guanabenz is a drug that belongs to the class of drugs known as centrally-acting alpha2 adrenergic agonists. It is used for the treatment of acute and chronic inflammatory conditions, infectious diseases, and cardiac disorders. Guanabenz has been shown to have anti-inflammatory activity in vivo and in vitro by inhibiting the proliferation of T cells and activation of macrophages. In addition, ganabenz has been shown to be effective as an adjunctive therapy to reduce inflammation in patients with congestive heart failure.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 231.08 g/mol
• Formule: C₈H₈Cl₂N₄
• Degré de pureté: Min. 95%